NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.

about

Hepatocyte growth factor and alternative splice variants - expression, regulation and implications in osteogenesis and bone health and repair

P2860

Q38760084-10C017E7-4978-49FC-9556-1F64E0424BE4

P2860

NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.

Item

http://www.wikidata.org/entity/Q39211399

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.

@en

NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.

@nl

type

Item

label

NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.

@en

NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.

@nl

prefLabel

NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.

@en

NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.

@nl

P1476

NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.

@en

P2093

Hong Yu

http://www.w3.org/2001/XMLSchema#string

Lin Miao

http://www.w3.org/2001/XMLSchema#string

Quanpeng Li

http://www.w3.org/2001/XMLSchema#string

Xianxiu Ge

http://www.w3.org/2001/XMLSchema#string

Youli Wang

http://www.w3.org/2001/XMLSchema#string

Yun Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Invasive growth: a MET-driven genetic programme for cancer and stem cells

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.

Cyclins and cell cycle checkpoints.

A function for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in fibroblasts during mitogenesis: requirement for insulin- and lysophosphatidic acid-mediated signal transduction.

Angiostatin and angiostatin-related proteins.

Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma

The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.

Mechanisms and significance of bifunctional NK4 in cancer treatment.

P2888

s10620-012-2523-7

P304

1636-1643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10620-012-2523-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23314853

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

gene therapy

NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.

about

P2860

P2860

NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921